A significant observation emerged: although the included studies were nearly consistent in finding no statistically significant difference in serum hepcidin levels between MDS patients and healthy volunteers, MDS patients consistently exhibited elevated serum hepcidin levels. The gene discussed is HAMP; the disease is myelodysplastic syndrome.